Form 4: Fulgent Genetics Officer Gao Hanlin Reports Stock Transaction
SEC Form 4
Fulgent Genetics' Chief Scientific Officer, Gao Hanlin, reports a transaction involving common stock to cover tax obligations.
Summary
- On April 26, 2025, Fulgent Genetics' Chief Scientific Officer, Gao Hanlin, reported a transaction involving the company's common stock.
- The transaction involved the withholding of 1,157 shares at a price of $18.88 to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, Gao Hanlin directly owns 963,153 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine stock transaction. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company executives.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of the Agreement and Plan of Merger by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. |
| November 9, 2022 | Date of the Form 4 filing with the U.S. Securities and Exchange Commission reporting the awards originally. |
| 04/26/2025 | Date of the stock transaction reported in this Form 4. |
| 04/29/2025 | Date of signature for the Form 4 filing. |
Keywords
Fulgent Genetics, Gao Hanlin, stock transaction, Form 4, insider trading, tax withholding, restricted stock units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.